Global Aprotinin Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.

Published by: GIR (GlobalInfoResearch)

Catalog: Pharma & Healthcare

Publishing Date: Nov 2016

Single User License: USD 3480

Corporate Users License: USD 4680

Delivery time: 24 hours

Pages: 115

Tables and Figures: 142

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=1325[url]

Scope of the Report:

This report focuses on the Aprotinin in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Sigma-Aldrich

BeiJing Geyuantianrun Bio-tech

Cayman Chemical

Taj Pharmaceuticals Limited

Guangdong Techpool Bio-pharma

Dadeli

A.S.Joshi&Company

Enzymeking Biotechnology

AdooQ BioScience

ProSpec

Yaxin Biotechnology

AMRESCO

PanReac AppliChem

Runhao

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

Latin America, Middle East and Africa

Market Segment by Type, covers

Aprotinin (From bovine lung)

Recombinant Aprotinin

Market Segment by Applications, can be divided into

Pharmaceuticals

Scientific Research & Experiment

There are 13 Chapters to deeply display the global Aprotinin market....